VistaGen Therapeutics (VTGN) reported Q2 revenue
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Wall Street ends lower as Alphabet revenue miss revives AI capex jitters
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
| (NASDAQ: VTGN) | Delayed: 0.17 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.17 | 52 Week High | $4.60 | |||
| Open | $0.17 | 52 Week Low | $2.81 | |||
| Day High | $0.17 | P/E | N/A | |||
| Day Low | $0.17 | EPS | $0.00 | |||
| Volume | 522,674 | |||||
